[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100583575":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":10,"centralContacts":23,"locations":33,"responsibleParty":50,"collaborators":54,"id":58,"slug":10,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":59,"sex":65,"minAge":66,"maxAge":10,"enrollmentInfo":67,"targetDuration":10,"studyType":70,"phases":10,"briefSummary":71,"conditions":72,"keywords":10,"overallStatus":35,"whyStopped":10,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"Semmelweis University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Hospital self audit data baseline before PBM training",null,"Anticipated 50 hospitals from Hungary, Romania, Czech Republic, Slovakia, Croatia, Austria. Only data about drugs\u002Fblood products used as medical routine will be recorded - no evaluation of any drug effect\u002Fefficacy.",[13],"Other: Data collection on interventions performs as per medical routine",{"label":15,"type":10,"description":16,"interventionNames":17},"Hospital self audit data after 6 month after PBM training","Anticipated 50 hospitals from Hungary, Romania, Czech Republic, Slovakia, Croatia, Austria.Only data about drugs\u002Fblood products used as medical routine will be recorded - no evaluation of any drug effect\u002Fefficacy.",[13],[19],{"type":6,"name":20,"description":21,"armGroupLabels":22,"otherNames":10},"Data collection on interventions performs as per medical routine","No intervention other than routine medical practice",[15,9],[24,29],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},"János Fazakas, Ass Prof","CONTACT","+36208258560","jancsidora@gmail.com",{"name":30,"role":26,"phone":31,"phoneExt":10,"email":32},"Anikó Smudla, MD","+36304362384","aniko_smudla@yahoo.com",[34],{"facility":5,"status":35,"city":36,"state":10,"zip":37,"country":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"RECRUITING","Budapest","1085","Hungary",{"type":40,"coordinates":41},"Point",[42,43],19.04045,47.49835,{"lat":43,"lon":42},[46,48],{"name":47,"role":26,"phone":27,"phoneExt":10,"email":28},"János Fazakas, Ass. Prof.",{"name":49,"role":26,"phone":31,"phoneExt":10,"email":32},"Aniko Smudla",{"type":51,"investigatorFullName":52,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Dr. Fazakas János","Associate Professor",[55],{"name":56,"class":57},"CSL Behring","INDUSTRY","100583575",false,"NCT06878105","Patient Blood Management Implementation in CEE Study","Evaluation of Fixed and Personal Assets for Patient Blood Management Implementation in CEE Countries in Practice","CEEPBM","Inclusion Criteria:\n\n* patients above 18 years of age\n* patients undergoing elective medium and high bleeding risk surgical intervention defined as moderate (\\\u003C500 ml) and high (≥ 500 ml)\n* patient consent\n\nExclusion Criteria:\n\n* no patient consent\n* patients under 18 years of age\n* pregnant patients\n* surgery with a low risk of bleeding\n* the patient underwent emergency (non-elective) surgery","ALL","18 Years",{"count":68,"type":69},2000,"ESTIMATED","OBSERVATIONAL","The goal of the study is data collection on available fixed and personal assets required for Patient Blood Management (elements of the 3 pillars of PBM) in Central Eastern Europe countries hospitals, status before and after PBM training.",[73,74],"Anemia","Coagulopathy","2025-03-10",{"date":77,"type":78},"2025-03-14","ACTUAL",{"date":80,"type":78},"2024-05-27",{"date":82,"type":69},"2025-12-31",{"name":5,"class":6},1]